MELD-Plus is a risk score to assess severity of chronic liver disease that was resulted from a collaboration between Massachusetts General Hospital and IBM.
The Model for End-Stage Liver Disease, or MELD, is a scoring system for assessing the severity of chronic liver disease. It was initially developed to ...
2020年6月14日 — This updated version of the 'MELD Score for Liver Disease' accounts for the patient's sodium level to better categorize patients with cirrhosis ...
The MELD score that he helped develop is used worldwide as a prognostic score for liver disease. His current focus is on finding ways to improve survival in ...
2012年9月7日 — The Model for End-Stage Liver Disease (MELD) is a reliable measure of mortality risk in patients with end-stage liver disease. It is used as a ...